The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy

Gang Zhang, Dongwei Guo, Prasanta K. Dash, Mariluz Araínga, Jayme L. Wiederin, Nicole A. Haverland, Jaclyn Knibbe-Hollinger, Andrea Martinez-Skinner, Pawel Ciborowski, Val S. Goodfellow, Tadeusz A. Wysocki, Beata J. Wysocki, Larisa Y. Poluektova, Xin Ming Liu, Jo Ellyn M. McMillan, Santhi Gorantla, Harris A. Gelbard, Howard E. Gendelman

Research output: Contribution to journalArticle

19 Scopus citations

Fingerprint Dive into the research topics of 'The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Engineering & Materials Science